Comparison of Piperacillin-tazobactam and Vancomycin (TZP-VAN) with Piperacillin-tazobactam and Teicoplanin (TZP-TEI) for the risk of Acute Kidney Injury (CONCOMITANT): A prospective observational, multinational, multi-centre cohort study

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 905aebbbeecf96ea-LAX IP: 47.97.18.252 UTC time: 2025-01-21T23:00:30+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4

View original article

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Like

Share Bookmark

0 0 0 0 0 0 0

More from this channel

Comparison of Piperacillin-tazobactam and Vancomycin (TZP-VAN) with Piperacillin-tazobactam and Teicoplanin (TZP-TEI) for the risk of Acute Kidney Injury (CONCOMITANT): A prospective observational, multinational, multi-centre cohort study

Comments (0)